Skip to content

Harrow HROW Compounding — Operating Income

Other segment segments

Imprimis Rx
$15.12M-52.6%
Branded
-$11.63M-278%

Similar metrics at other companies

Hexcel logo
HXLComposite Materials — Operating Income
$69.7M+27.7%
Brunswick logo
BCCorporate Segment — Operating Income (Loss)
-$41.3M-22.2%
The Greenbrier Companies logo
GBXManufacturing — Operating Income
$20.7M-74.4%
KBR logo
KBRCorporate — Operating Income
-$44M-15.8%
Rumble, Inc. logo
RUMOperating Income
-$39.1M-7.5%
CHE
CHEOperating Income
$84.58M-10.7%

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.59B+38.4%
Enterprise value$1.81B+13.8%
P/S5.9×+0.5×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's compounding — operating income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harrow's compounding — operating income?
Harrow (HROW) reported compounding — operating income of $343K in Q1 2026.
What does compounding — operating income mean?
This metric measures the profitability of the compounding segment after accounting for both the direct costs of production and all associated operating expenses. It serves as the definitive indicator of the segment's operational health and its contribution to the overall company bottom line. Investors use this to evaluate the segment's ability to generate sustainable returns on invested capital.